# TAZVERIK

NDC: 72607-100
Generic name: tazemetostat
Labeler / Manufacturer: Epizyme, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20200123
Marketing ended: 20290430
FDA application: NDA211723

## Active ingredients

- TAZEMETOSTAT HYDROBROMIDE: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72607-100"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72607-100
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7db07b5f-4e22-467c-9c0a-f830b08dbb1d